Hilary Reznick, PA
Medical · Chandler, AZNPI 1902180656
Payments from drug & device makers
Across 779 payments — averaging $16.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$2K
- AbbVie$2K
- Johnson & Johnson$1K
- Novartis$1K
- Sanofi$1K
- Incyte Corporation$732
- plus $5K from 28 others
What the payments were for
- Food & beverage$12,52797%
- Education$3303%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 93 | $1,847 |
| AbbVie | 101 | $1,551 |
| Johnson & Johnson | 97 | $1,448 |
| Novartis | 70 | $1,447 |
| Sanofi | 50 | $1,010 |
| Incyte Corporation | 56 | $732 |
| Regeneron Healthcare Solutions, Inc. | 31 | $644 |
| UCB, Inc. | 65 | $588 |
| Lilly USA, LLC | 21 | $497 |
| Pfizer | 35 | $482 |
| Sun Pharmaceutical Industries Inc. | 35 | $376 |
| Amgen | 14 | $369 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 24 | $313 |
| E.r. Squibb & Sons, L.L.C. | 16 | $266 |
| Kyowa Kirin, Inc. | 12 | $215 |
| Arcutis Biotherapeutics, Inc. | 9 | $169 |
| Dermavant Sciences, Inc. | 8 | $148 |
| Mayne Pharma Commercial LLC | 9 | $134 |
| Genentech USA, Inc. | 5 | $111 |
| Organon | 5 | $65 |
| VYNE Pharmaceuticals Inc. | 2 | $48 |
| Biofrontera Inc. | 2 | $45 |
| Almirall LLC | 2 | $42 |
| Hill Dermaceuticals, Inc. | 1 | $42 |
| Galderma Laboratories, L.p. | 3 | $41 |
| Botanix SB Inc | 2 | $39 |
| Biowound Solutions, Inc. | 3 | $37 |
| Boehringer Ingelheim | 2 | $35 |
| Krystal Biotech Inc | 1 | $28 |
| Fresenius Kabi USA, LLC | 1 | $25 |
| Biocon Biologics Inc | 1 | $23 |
| Journey Medical Corporation | 1 | $15 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
| Stemline Therapeutics Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADBRY$125
How this compares
$12,856 in reported general payments places this provider in the 95th percentile of 748 medical providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 70 | $2,799 |
| Tacrolimus | 16 | $1,891 |
| Ketoconazole | 77 | $1,699 |
| Fluorouracil | 22 | $1,491 |
| Doxycycline Hyclate | 25 | $1,007 |
| Dutasteride | 21 | $803 |
| Metronidazole | 16 | $789 |
| Imiquimod | 17 | $778 |
| Triamcinolone Acetonide | 83 | $505 |
| Ciclopirox | 14 | $377 |
| Fluocinonide | 12 | $364 |
| Mupirocin | 30 | $220 |
| Doxycycline Monohydrate | 12 | $170 |
Paid to pharmacies, not to this prescriber.
Other medical in Chandler
- Nicole HenseyChandler$18K
- Beth LopezChandler$13K
- Maura TardifChandler$9K
- Yuliya SchoenlingChandler$8K
- Robert CasquejoScottsdale$474K
- Andrew HicksPeoria$460K
- Darren WestScottsdale$206K
- Linda MoorsTucson$122K
- Jamie WystrachScottsdale$79K
- Scott YoungPhoenix$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.